TONIX PHARMACEUTICALS HLDG C
TNXP·890260839·US·Common Stock·Healthcare - Biotechnology-13D/G
TNXP (TONIX PHARMACEUTICALS HLDG C) is held by 56 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($13.3M), VANGUARD CAPITAL MANAGEMENT LLC ($7.1M), CITADEL ADVISORS LLC ($6.4M). Net institutional sentiment: Mixed.
56
Holders
Avg rating(13 Elite)
$59.4M
Total Value
67% (61)
Fund Consensus
36 buying - 18 selling
Who's Trading
InsiderTETaylor Carolyn E.Buy $15KJun 12, 2026
ActivistSISirenia Capital Management LP8.8%May 15, 2026
InsiderLSLEDERMAN SETHBuy $63KMar 31, 2026
InsiderLSLEDERMAN SETHBuy $223KMar 18, 2026
InsiderTETaylor Carolyn E.Buy $15KAug 21, 2025
InsiderTJTreco JamesBuy $9KAug 20, 2025
13F: Insider & Congress:
Showing 1-20 of 61
1 / 4
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer